Albumin‐Mediated Delivery of Bioactive Peptides for Pancreatic Cancer Therapy
Yue Du(Shandong University of Technology), Jian Xu(University of California, Los Angeles), Hongfei Yi(Sichuan University), Yongliang Yuan(First Affiliated Hospital of Zhengzhou University), Yong‐Su Zhen(Chinese Academy of Medical Sciences & Peking Union Medical College), Bo-Yang Shang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 4
Related Papers
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
|Pharmacology & Therapeutics|2019|245
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations
|Nature Genetics|2011|198
Nanoparticle Systems for Cancer Vaccine
|Nanomedicine|2019|145